Search

everythinglearnresearchcommunity

for

Search:↓

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Human prenatal skin develops an immune network early on that helps with skin formation and healing without scarring.

Immune cells help keep skin healthy and repair it, but imbalance can cause disease.

Stem cell treatment from umbilical cords reduces symptoms of atopic dermatitis and may help hair growth.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.

The study suggests that mast cells might be involved in the hair loss condition telogen effluvium and could be a target for treatment.

Cells from the lower part of hair follicles are a promising, less invasive option for immune system therapies.

Sorafenib causes skin reactions by increasing the number and activity of skin mast cells.

Two mouse mutations cause similar hair loss despite different skin changes.

Epimedium extract helps increase skin pigmentation and could be a new treatment for conditions with reduced pigmentation.

UV light helped human hair transplants survive in mice without broad immunosuppression.

Hair graying is influenced by factors like nerves, fat cells, and immune cells, not just hair follicles.

Mesenchymal stem cells and their vesicles may effectively treat skin diseases, but more research is needed.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

Children and adults with Cushing's disease show different symptoms and males have more severe cases; surgery outcomes can be predicted by certain factors.

The conclusion is that understanding the complex relationship between allergies, autoimmunity, and psychological factors is key to treating skin disorders with itching.

Permanent hair dye may cause total hair loss.

The dog with an Alopecia Areata-like condition showed signs of an autoimmune disease and partially regrew hair without treatment, suggesting dogs could be models for human AA research.

The skin protects the body, regulates temperature, senses touch, and makes vitamin D.

γδ T cells are essential for wound healing after poxvirus infection.

The IGRA test effectively detects past SARS-CoV-2 exposure, especially using nucleocapsid peptides.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

T cells affect skin cell genes in inflammatory diseases, and therapy can normalize these changes.

Keloid skin disorder involves abnormal fibroblast activation and immune response, linked to a group of genes including FGF11.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Micro-injury can help regrow hair and repigment vitiligo by activating specific cells.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Hair loss in a drug reaction case involved both a common shedding phase and an immune attack on hair follicle stem cells.

The meeting highlighted major advances in skin research, including new findings on skin microbes, genetic links to skin diseases, and improved treatments for various conditions.